Business

Mass. Attorney General warns Gilead to lower price of hepatitis C medicines

By Robert Weisman — Boston Globe

January 27, 2016

AP

AG calls on Gilead to lower price of hepatitis C medicines

About the Author

Robert Weisman — Boston Globe

Leave a Comment

Please enter your name.
Please enter a comment.

Trending
Epidiolex
Panel recommends FDA approval of epilepsy drug derived from…
Panel recommends FDA approval of epilepsy drug derived from marijuana
Hoarding Opioids
In the throes of an opioid crisis, prescriptions fell…
In the throes of an opioid crisis, prescriptions fell dramatically last year
Heroin and Fentanyl doses
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
Recommended
Pharmaceutical company Takeda
Shire rejects Takeda’s $60 billion takeover bid
Shire rejects Takeda’s $60 billion takeover bid
Supreme Court weighs whether to review a whistleblower case…
Supreme Court weighs whether to review a whistleblower case against Gilead
Amazon direct care illo
Can Amazon cut insurers out of primary care?
Can Amazon cut insurers out of primary care?

Recommended Stories

Generics
Politics

One reason for high drug prices: a huge backlog of unapproved generic drugs

By Sheila Kaplan

Concussion Data Football
Politics

NFL’s ‘unrestricted’ grant to fund brain research has strings attached

By Ike Swetlitz

Voting booth
Pharmalot

State measures to slash drug prices face big hurdles

By Ed Silverman

Shkreli
Pharmalot

Martin Shkreli would violate bail if he testifies before Congress

By Ed Silverman

Politics

Why Donald Trump would have the same problems as Democrats on Medicare drug prices

By David Nather

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.